Perbedaan Brigit Biofarmaka Teknologi Tbk. dan KDB Tifa Finance Tbk.: Brigit Biofarmaka Teknologi Tbk. diperdagangkan di Rp254 (kapitalisasi pasar 172,82 M, volume 24 jam 592,2 rb), sedangkan KDB Tifa Finance Tbk. diperdagangkan di Rp304 (kapitalisasi pasar 866,74 M, volume 24 jam 1,53 jt). Perbedaan utamanya: KDB Tifa Finance Tbk. jauh lebih besar — sekitar 5× kapitalisasi pasar Brigit Biofarmaka Teknologi Tbk., dan KDB Tifa Finance Tbk. lebih aktif diperdagangkan (1,53 jt vs 592,2 rb). Mana yang lebih baik tergantung tujuan investasimu.
| OBAT | TIFA | |
|---|---|---|
Kapitalisasi Pasar | 172,82 M | 866,74 M |
Volume | 592,2 rb | 1,53 jt |
Lot | 5,92 rb | 15,29 rb |
Perputaran | 147,05 jt | 450,9 jt |
Harga Rata-rata | 248,31 | 294,96 |
Nilai Transaksi | 147,05 jt | 450,9 jt |
Harga Ekuilibrium Indikatif | 254 | 304 |
Volume Ekuilibrium Indikatif | 10 | 4 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Selengkapnya di halaman OBAT →PT Tifa Finance Tbk (the company) was established under its original name of PT Tifa Mutual Finance Corporation base on notarial deed No.42 of Esther Daniar, S.H, dated on 14 Jun, 1989. The Company’s articles of association has been amended several times, most recently by notarial deed No. 1 of Fathiah Helmi, S.H., dated Aug 2, 2010, concerning among others, the change in the Company’s name, and public offering.
Selengkapnya di halaman TIFA →